Centerline Biomedical
PrivateLast Round
Series B
Jun 27, 2022
Total Funding Raised
$51.93M
Company Overview
Centerline Biomedical operates in Healthcare & Life Sciences and is based in Cleveland, Ohio. Its latest recorded funding round was a Series B round in June 2022.
Centerline Biomedical is a medical technology company that develops a three-dimensional visualization and real-time navigation system aimed at enhancing endovascular procedures while minimizing radiation exposure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centerline Biomedical Comparables
Compare Centerline Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediView XR, Inc. | 84% | |
| Cydar Medical | 84% | |
| Medivis | 76% |
For institutional investors. Book with your work email.
Centerline Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 27, 2022 | ||||
| Grant | Apr 22, 2020 | ||||
| Grant | Sep 12, 2019 | ||||
| Grant | Aug 11, 2018 | ||||
| Grant | Apr 3, 2017 | ||||
Series A | Dec 13, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Centerline Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JumpStart Ventures | Series B |
| Cleveland Clinic Ventures | Series B |
| NIH RADx | Grant |
| Ohio Third Frontier | Grant |
| Ohio Third Frontier | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| RIK Enterprises | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 121% MoM, reaching 3.5K.
- Apr 22, 2020
$1.5M grant from NIH RADx and NHLBI
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 10, 2026
Centerline Biomedical launches the IOPS Visionary System in the United States on Nov 10th '26 in Ohio, adding live fluoroscopic overlays, direct tableside physician interaction, and modernized system architecture for image-guided endovascular navigation.
For institutional investors. Book with your work email.
Centerline Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Centerline Biomedical's valuation, stock price, and market status.
Is Centerline Biomedical a public or private company?
Centerline Biomedical is a private company.
What is the current stock price of Centerline Biomedical?
Centerline Biomedical is a private company, so its shares have no public market price. Caplight tracks Centerline Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Centerline Biomedical worth (valuation)?
Valuation information for Centerline Biomedical is not publicly available.
Can I buy Centerline Biomedical stock?
Centerline Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Centerline Biomedical's last funding round?
Centerline Biomedical's most recent funding round was Series B on June 27, 2022.
Who are the main investors in Centerline Biomedical?
Key investors in Centerline Biomedical include Cleveland Clinic Ventures.
Will Centerline Biomedical IPO soon?
No public IPO plans have been announced for Centerline Biomedical.
How can I track Centerline Biomedical secondary market activity?
Caplight tracks bids, offers, and trades in Centerline Biomedical's shares on secondary markets.